UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Human breast tumor-infiltrating CD8 + T cells retain polyfunctionality despite PD-1 expression

Nature communications, 2018-10, Vol.9 (1), p.4297-11, Article 4297

2018

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Checkpoint of Immune Cells in Melanoma Brain Metastases

Cancer discovery, 2019-05, Vol.9 (5), p.581-583

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor‐Positive Metastatic Triple‐Negative Breast Cancer

The oncologist (Dayton, Ohio), 2021-02, Vol.26 (2), p.99-e217

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer

European journal of cancer (1990), 2021-09, Vol.154, p.11-20

2021

Link zum Volltext

Verfügbarkeit prüfen

Mature Dendritic Cells May Promote High-Avidity Tuning of Vaccine T Cell Responses

Frontiers in immunology, 2020-10, Vol.11, p.584680-584680

2020

Link zum Volltext

Verfügbarkeit prüfen

1012 Differentiation pathways of exhausted CD8+ T cells in human breast tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1120-A1120

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

Cancer Immunology, Immunotherapy, 2023-09, Vol.72 (9), p.3013-3027

2023

Link zum Volltext

Verfügbarkeit prüfen

A Pilot Feasibility Study of Yttrium‐90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases

The oncologist (Dayton, Ohio), 2020-05, Vol.25 (5), p.382-e776

2020

Link zum Volltext

Verfügbarkeit prüfen

STING signalling compensates for low tumour mutation burden to drive anti-tumour immunity

EBioMedicine, 2024-03, Vol.101, p.105035-105035, Article 105035

2024

Link zum Volltext

Verfügbarkeit prüfen

Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients

JCI insight, 2019-10, Vol.4 (19)

2019

Link zum Volltext

Verfügbarkeit prüfen

Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer

Cancers, 2022-06, Vol.14 (13), p.3159

2022

Link zum Volltext

Verfügbarkeit prüfen

Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data

International journal of molecular sciences, 2021-02, Vol.22 (5), p.2316

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR

Proceedings of the National Academy of Sciences - PNAS, 2016-07, Vol.113 (29), p.8272-8277

2016

Link zum Volltext

Verfügbarkeit prüfen

Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies

NPJ precision oncology, 2024-03, Vol.8 (1), p.81-81

2024

Link zum Volltext

Verfügbarkeit prüfen

Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines

Proceedings of the National Academy of Sciences - PNAS, 2008-10, Vol.105 (42), p.16260-16265

2008

Link zum Volltext

Verfügbarkeit prüfen

Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Cancer research communications, 2023-10, Vol.3 (10), p.2082-2095

2023

Link zum Volltext

Verfügbarkeit prüfen

1035 CD26+ CD4+ T cells impart enhanced anti-tumor immunity and improved prognosis in early-stage breast cancer patients

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1142-A1142

2023

Link zum Volltext

Verfügbarkeit prüfen

Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy

Frontiers in immunology, 2024-01, Vol.14, p.1274781-1274781

2024

Link zum Volltext

Verfügbarkeit prüfen

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231210675

2023

Link zum Volltext

Verfügbarkeit prüfen

Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer

JCI insight, 2022-02, Vol.7 (3)

2022

Link zum Volltext

Verfügbarkeit prüfen

PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer

Cell reports. Medicine, 2024-02, Vol.5 (2), p.101420-101420, Article 101420

2024

Link zum Volltext

Verfügbarkeit prüfen

937 Comprehensive immune profiling unravels evolution of spatial distribution and immune repertoire in tumor microenvironment from primary to metastatic triple negative breast cancers

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1041-A1041

2023

Link zum Volltext

Verfügbarkeit prüfen

Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e002084

2021

Link zum Volltext

Verfügbarkeit prüfen

PD-1 blockade does not enhance T cell reactivity to autologous tumor cells ex vivo in breast cancer. (TUM2P.1013)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.69-69.10

Egelston, Colt

2015

Link zum Volltext

Verfügbarkeit prüfen

Arhgap25 Deficiency Leads to Decreased Numbers of Peripheral Blood B Cells and Defective Germinal Center Reactions

ImmunoHorizons, 2020-05, Vol.4 (5), p.274-281

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(22)
Humans
(16)
Breast Cancer
(13)
Immunotherapy
(12)
Oncology
(12)
Female
(9)
Immunology
(8)
Metastasis
(8)
Animals
(7)
Lymphocytes
(7)
Mice
(7)
Patients
(7)
Biomarkers
(6)
Tumors
(6)
Metastases
(5)
Mutation
(5)
Tumor Microenvironment
(5)
Cd8-Positive T-Lymphocytes - Metabolism
(4)
Ligands
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Human breast tumor-infiltrating CD8 + T cells retain polyfunctionality despite PD-1 expression

Metabolic Checkpoint of Immune Cells in Melanoma Brain Metastases

A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor‐Positive Metastatic Triple‐Negative Breast Cancer

Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer

Mature Dendritic Cells May Promote High-Avidity Tuning of Vaccine T Cell Responses

1012 Differentiation pathways of exhausted CD8+ T cells in human breast tumors

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

A Pilot Feasibility Study of Yttrium‐90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases

STING signalling compensates for low tumour mutation burden to drive anti-tumour immunity

Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients

Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer

Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data

Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR

Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies

Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines

Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

1035 CD26+ CD4+ T cells impart enhanced anti-tumor immunity and improved prognosis in early-stage breast cancer patients

Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer

PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer

937 Comprehensive immune profiling unravels evolution of spatial distribution and immune repertoire in tumor microenvironment from primary to metastatic triple negative breast cancers

Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer

PD-1 blockade does not enhance T cell reactivity to autologous tumor cells ex vivo in breast cancer. (TUM2P.1013)

Arhgap25 Deficiency Leads to Decreased Numbers of Peripheral Blood B Cells and Defective Germinal Center Reactions

Suchergebnisse filtern